SME Times is powered by   
Search News
Just in:   • Centre kicks off e-Bill System for handling Rs 2 lakh crore fertiliser subsidy  • Centre’s fiscal deficit in April-November at 62.3 pc of full year estimate, govt capex goes up  • India poised to step up trade talks with Israel, Russia in next two months  • FIEO hails Govt's market access support intervention to boost exports  • Auto PLI scheme sees Rs 35,657 crore investment, incentives worth Rs 2,322 crore disbursed 
Last updated: 01 Feb, 2017  

cadila.thumb.jpg Cadila Healthcare net profit declines 34.6 pc in Q3

cadila.jpg
   Top Stories
» Centre kicks off e-Bill System for handling Rs 2 lakh crore fertiliser subsidy
» India poised to step up trade talks with Israel, Russia in next two months
» Auto PLI scheme sees Rs 35,657 crore investment, incentives worth Rs 2,322 crore disbursed
» ONDC democratised e-commerce and empowered small sellers: Piyush Goyal
» India’s 2025 economic reforms lay foundation for inclusive growth
SME Times News Bureau | 01 Feb, 2017
Global pharmaceutical company Cadila Healthcare on Tuesday posted a 34.6 percent decline in its consolidated net profit to Rs 281.6 crore for the quarter ended December 31, 2016 as compared with Rs 430.5 crore in the year-ago period.

The company's consolidated total income from operations also dipped to Rs 2,363.8 crore during the quarter under review as compared with Rs 2,408.9 crore in a year-ago period.

On BSE, the stock settled at Rs 349.25, down 7.02 percent from the previous close.
 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹91.25
₹89.55
UK Pound
₹122.85
₹118.85
Euro
₹107.95
₹104.3
Japanese Yen ₹59 ₹57.1
As on 29 Dec, 2025
  Daily Poll
What is your biggest hurdle to scaling right now?
 Cash flow issues
 Material costs
 Finding leads
 Adopting AI
 Hiring Talent
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter